Xeljanz, also known by its generic name tofacitinib, is a Janus kinase (JAK) inhibitor used to treat certain autoimmune conditions. As of now, there are no generic versions of Xeljanz available in the United States [1].
When will generic Xeljanz be available?
The availability of generic versions of Xeljanz depends on patent expirations and any ongoing legal challenges to those patents. The original patents for tofacitinib are set to expire in the coming years. However, the exact date for the launch of a generic tofacitinib can be influenced by litigation and regulatory approvals [2].
What are the patents on Xeljanz?
Xeljanz has several patents protecting its composition, method of use, and manufacturing processes. These patents are held by Pfizer, the original manufacturer. Information on specific patent numbers and their expiration dates can be found through resources like DrugPatentWatch.com [2].
Who makes Xeljanz?
Xeljanz is manufactured by Pfizer [1].
What conditions does Xeljanz treat?
Xeljanz is prescribed for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who have had an inadequate response or intolerance to other treatments [1].
How does tofacitinib work?
Tofacitinib works by blocking the activity of Janus kinases (JAKs), enzymes involved in signaling pathways that regulate immune cell function and inflammation. By inhibiting these pathways, tofacitinib helps reduce inflammation and the symptoms associated with autoimmune diseases [1].
What are the risks associated with Xeljanz?
Xeljanz carries a boxed warning regarding serious infections, including tuberculosis and invasive fungal infections, as well as an increased risk of blood clots, stroke, heart attack, and certain cancers. Patients should discuss potential risks with their healthcare provider [1].
Are there alternative treatments for Xeljanz?
Yes, there are alternative treatment options for the conditions Xeljanz treats, including other biologic medications and different classes of drugs. The choice of treatment depends on the specific condition, its severity, and individual patient factors [1].
What is the cost of Xeljanz?
The cost of Xeljanz can vary significantly depending on insurance coverage, pharmacy, and dosage. Without insurance, the out-of-pocket cost can be substantial [1]. The introduction of generic alternatives typically leads to lower prices.
Sources:
[1] https://www.xeljanz.com/
[2] https://drugpatentwatch.com/